![1]()
News
Large population-based study underscores link between gout, CVD event risk
November 23, 2019
ATLANTA – The relationships between gout and fatal and nonfatal CVD events found in a large population-based health data linkage study in New Zealand were not ameliorated by allopurinol use or serum urate lowering to treatment target.
News
Hyperkalemia-related treatment changes linked to death in acute HF
November 21, 2019
It’s not the potassium, but the subsequent dosage reduction, that may boost mortality after hospitalization for acute heart failure.
![1]()
News
Risk stratification of syncope patients can help determine duration of telemetry monitoring
November 12, 2019
In ED patients with syncope, what is the optimal duration of telemetry monitoring to detect underlying arrhythmia?
![1]()
News
Better time data from in-hospital resuscitations
November 11, 2019
Acquiring accurate time-interval data is “the key to future high-quality research.”
![1]()
News
Aspirin for primary prevention reduces risk of CV events, increases bleeding
November 8, 2019
What is the association between aspirin for primary prevention and cardiovascular events and bleeding?
![1]()
News
Spanish risk score predicts 30-day mortality in acute HF in ED patients
November 7, 2019
Is the MEESSI-AHF score valid to use in EDs in Switzerland?
![1]()
News
Oral antibiotics as effective as IV for stable endocarditis patients
November 6, 2019
Can patients with left-sided endocarditis safely switch from intravenous to oral antibiotics?
![1]()
News
New score predicts benefits of prolonged cardiac monitoring for TIA, stroke patients
November 5, 2019
How can we determine which patients would benefit from prolonged cardiac monitoring after a neurologic event?
![1]()
News
How P-wave indices can improve AFib-related ischemic stroke prediction
November 1, 2019
Do the addition of P-wave indices (PWIs) measurements to the CHA2DS2-VASc score improve the ability to predict atrial fibrillation (AFib)–related ischemic stroke?
![1]()
News
Dose-reduced NOACs may be safer than warfarin in some AFib patients
October 31, 2019
Are dose-reduced non–vitamin K antagonist oral anticoagulants (NOACs) safer or more effective than warfarin is in patients with atrial fibrillation who are eligible for a dose-reduced NOAC?
